US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 1.8800
  • -0.1200-6.00%
Close Jun 10 16:00 ET
2.75MMarket Cap-85P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
29K
420K
31K
16K
373K
0
0
0
0
0
Operating revenue
--29K
--420K
--31K
--16K
--373K
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-40.10%4.38M
-6.45%25.87M
-39.05%5.39M
6.09%6.86M
8.94%6.3M
11.59%7.32M
23.52%27.66M
47.79%8.85M
7.82%6.47M
-5.16%5.79M
Selling and administrative expenses
-3.83%1.58M
-8.99%6.72M
-12.60%1.87M
-20.89%1.63M
-0.32%1.58M
2.49%1.65M
-1.06%7.38M
10.41%2.14M
15.33%2.05M
-20.96%1.58M
-General and administrative expense
-3.83%1.58M
-8.99%6.72M
-12.60%1.87M
-20.89%1.63M
-0.32%1.58M
2.49%1.65M
-1.06%7.38M
10.41%2.14M
15.33%2.05M
-20.96%1.58M
Research and development costs
-50.62%2.8M
-5.52%19.16M
-47.51%3.52M
18.65%5.24M
12.41%4.73M
14.53%5.67M
35.81%20.27M
65.73%6.7M
4.65%4.41M
2.54%4.21M
Operating profit
40.50%-4.36M
7.97%-25.45M
39.40%-5.36M
-5.85%-6.85M
-2.49%-5.93M
-11.59%-7.32M
-23.52%-27.66M
-47.79%-8.85M
-7.82%-6.47M
5.16%-5.79M
Net non-operating interest income expense
-98.28%2K
26.67%266K
-81.15%23K
-25.37%50K
352.94%77K
2,800.00%116K
1,212.50%210K
2,950.00%122K
1,575.00%67K
325.00%17K
Non-operating interest income
-98.28%2K
26.67%266K
-81.15%23K
-25.37%50K
352.94%77K
2,800.00%116K
1,212.50%210K
2,950.00%122K
1,575.00%67K
325.00%17K
Other net income (expense)
-32.91%53K
-123.78%-364K
-28.52%-356K
-67.24%95K
-187.08%-182K
-93.96%79K
714.36%1.53M
-810.26%-277K
3,122.22%290K
4,080.00%209K
Gain on sale of security
101.15%1K
-277.68%-414K
-26.69%-356K
-62.32%104K
-136.36%-76K
-400.00%-87K
429.55%233K
-820.51%-281K
2,966.67%276K
1,707.69%209K
Other non- operating income (expenses)
-68.67%52K
-96.15%50K
--0
-164.29%-9K
---106K
-87.03%166K
801.39%1.3M
--4K
--14K
----
Income before tax
39.64%-4.3M
1.40%-25.55M
36.74%-5.69M
-9.66%-6.7M
-8.54%-6.03M
-35.80%-7.12M
-16.81%-25.92M
-51.46%-9M
-2.09%-6.11M
8.73%-5.56M
Income tax
-2.58%-1.35M
36.49%-3M
73.31%-422K
34.12%-668K
40.45%-586K
-15.99%-1.32M
-26.53%-4.72M
-46.66%-1.58M
-1.60%-1.01M
-2.07%-984K
Net income
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
-2.19%-5.1M
10.77%-4.58M
Net income continuous Operations
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
-2.19%-5.1M
10.77%-4.58M
Minority interest income
Net income attributable to the parent company
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
-2.19%-5.1M
10.77%-4.58M
Preferred stock dividends
0.00%201K
0.00%50K
0.00%50K
0.00%50K
0.00%50K
0.00%201K
0.00%50K
0.00%50K
0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders
49.68%-2.95M
-6.34%-22.76M
28.76%-5.32M
-18.19%-6.08M
-18.88%-5.5M
-40.79%-5.85M
-14.69%-21.4M
-51.99%-7.47M
-2.16%-5.15M
10.66%-4.63M
Basic earnings per share
67.57%-2.27
6.79%-26.75
30.78%-6.23
-11.63%-7.2
4.35%-6.6
-11.11%-7
8.45%-28.7
-11.11%-9
20.37%-6.45
17.86%-6.9
Diluted earnings per share
67.57%-2.27
6.79%-26.75
30.78%-6.23
-11.63%-7.2
4.35%-6.6
-11.11%-7
8.45%-28.7
-11.11%-9
20.37%-6.45
17.86%-6.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 29K420K31K16K373K00000
Operating revenue --29K--420K--31K--16K--373K--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -40.10%4.38M-6.45%25.87M-39.05%5.39M6.09%6.86M8.94%6.3M11.59%7.32M23.52%27.66M47.79%8.85M7.82%6.47M-5.16%5.79M
Selling and administrative expenses -3.83%1.58M-8.99%6.72M-12.60%1.87M-20.89%1.63M-0.32%1.58M2.49%1.65M-1.06%7.38M10.41%2.14M15.33%2.05M-20.96%1.58M
-General and administrative expense -3.83%1.58M-8.99%6.72M-12.60%1.87M-20.89%1.63M-0.32%1.58M2.49%1.65M-1.06%7.38M10.41%2.14M15.33%2.05M-20.96%1.58M
Research and development costs -50.62%2.8M-5.52%19.16M-47.51%3.52M18.65%5.24M12.41%4.73M14.53%5.67M35.81%20.27M65.73%6.7M4.65%4.41M2.54%4.21M
Operating profit 40.50%-4.36M7.97%-25.45M39.40%-5.36M-5.85%-6.85M-2.49%-5.93M-11.59%-7.32M-23.52%-27.66M-47.79%-8.85M-7.82%-6.47M5.16%-5.79M
Net non-operating interest income expense -98.28%2K26.67%266K-81.15%23K-25.37%50K352.94%77K2,800.00%116K1,212.50%210K2,950.00%122K1,575.00%67K325.00%17K
Non-operating interest income -98.28%2K26.67%266K-81.15%23K-25.37%50K352.94%77K2,800.00%116K1,212.50%210K2,950.00%122K1,575.00%67K325.00%17K
Other net income (expense) -32.91%53K-123.78%-364K-28.52%-356K-67.24%95K-187.08%-182K-93.96%79K714.36%1.53M-810.26%-277K3,122.22%290K4,080.00%209K
Gain on sale of security 101.15%1K-277.68%-414K-26.69%-356K-62.32%104K-136.36%-76K-400.00%-87K429.55%233K-820.51%-281K2,966.67%276K1,707.69%209K
Other non- operating income (expenses) -68.67%52K-96.15%50K--0-164.29%-9K---106K-87.03%166K801.39%1.3M--4K--14K----
Income before tax 39.64%-4.3M1.40%-25.55M36.74%-5.69M-9.66%-6.7M-8.54%-6.03M-35.80%-7.12M-16.81%-25.92M-51.46%-9M-2.09%-6.11M8.73%-5.56M
Income tax -2.58%-1.35M36.49%-3M73.31%-422K34.12%-668K40.45%-586K-15.99%-1.32M-26.53%-4.72M-46.66%-1.58M-1.60%-1.01M-2.07%-984K
Net income 49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M-2.19%-5.1M10.77%-4.58M
Net income continuous Operations 49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M-2.19%-5.1M10.77%-4.58M
Minority interest income
Net income attributable to the parent company 49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M-2.19%-5.1M10.77%-4.58M
Preferred stock dividends 0.00%201K0.00%50K0.00%50K0.00%50K0.00%50K0.00%201K0.00%50K0.00%50K0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders 49.68%-2.95M-6.34%-22.76M28.76%-5.32M-18.19%-6.08M-18.88%-5.5M-40.79%-5.85M-14.69%-21.4M-51.99%-7.47M-2.16%-5.15M10.66%-4.63M
Basic earnings per share 67.57%-2.276.79%-26.7530.78%-6.23-11.63%-7.24.35%-6.6-11.11%-78.45%-28.7-11.11%-920.37%-6.4517.86%-6.9
Diluted earnings per share 67.57%-2.276.79%-26.7530.78%-6.23-11.63%-7.24.35%-6.6-11.11%-78.45%-28.7-11.11%-920.37%-6.4517.86%-6.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg